FIELD: medicine.
SUBSTANCE: invention relates to medical drug for respiratory disorders treatment. The invention comprises rated dose of dry powder tiotropium drug placed and hermetically sealed directly in the tank acting as dry sealing layer to prevent moisture penetration in tiotropium powder. Then tiotropium dose is to be adapted for inhalation and the tank is quite sealed to prevent moisture attack on the dose effectiveness when delivering. In another aspect of the invention the inhalator is provided wherein at least one hermetically sealed moisture-proof container with teotropium dose can be fed to deliver the latter with constant dose of fine particles during scheduled period of product storage.
EFFECT: efficiency upgrading.
20 cl, 3 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PRE-DOSED DRY POWDER INHALER FOR MOISTURE-SENSITIVE MEDICINES | 2004 |
|
RU2372946C2 |
| INHALATION COMPOSITIONS CONTAINING MONTELEUKAST ACID AND PDE-4 INHIBITOR OR INHALATION CORTICOSTEROID | 2008 |
|
RU2470639C2 |
| INHALED PARTICLES CONTAINING TIOTROPIUM | 2009 |
|
RU2685236C2 |
| COMBINATIONS CONTAINING ANTI-MUSCARINE PREPARATIONS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2379033C2 |
| CAPSULES FOR INHALERS | 2006 |
|
RU2412722C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2404771C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385156C2 |
| RAPAMYCIN-CONTAINING COMPOSITION ADMINISTERED BY INHALATION FOR TREATING AGE-RELATED DISEASES | 2015 |
|
RU2718583C2 |
| RAPAMYCIN FOR TREATING LYMPHANGIOLEIOMYOMATOSIS | 2014 |
|
RU2707285C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385721C2 |
